Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 16Head & Neck 7Genitourinary 4Lymphoid 3Endocrine 3CNS 3Sarcoma 2Other hematologic neoplasm 2Breast 2Thoracic 1Plasma cell 1Other 1Myeloid 1Dermatologic 1Classical hematology 1

Conditions

Mouth Neoplasms 1Fanconi Anemia 1

Interventions

Cyclophosphamide 94fludarabine phosphate 87Busulfan 64Cyclosporine 57Epoetin Alfa 55Peripheral Blood Stem Cell Transplantation 54Mycophenolic Acid 54Whole-Body Irradiation 53fludarabine 45Antilymphocyte Serum 43Filgrastim 41Cytarabine 41Melphalan 40Tacrolimus 39Darbepoetin alfa 39Methotrexate 34Radiotherapy 33Cord Blood Stem Cell Transplantation 28Granulocyte Colony-Stimulating Factor 23apixaban 22Methylprednisolone 22Rivaroxaban 21Etoposide 21Thiotepa 17Dalteparin 17eltrombopag 16ferric carboxymaltose 14epoetin beta 14Daunorubicin 14Azacitidine 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ethanol × Classical hematology × Clear all
NCT05973656 2025-08-22

Role of Acetaldehyde in the Development of Oral Cancer

Masonic Cancer Center, University of Minnesota

Phase NA Recruiting
170 enrolled
Classical hematologyHead & Neck

Fanconi Anemia, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡